Entasis Therapeutics Holdings ETTX

$ 2.19 0.0%

Quarterly report 2022-Q1
added 12-23-2023

Entasis Therapeutics Holdings Financial Statements 2011-2024 | ETTX

Annual Financial Statements Entasis Therapeutics Holdings

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	73.7 M	64 M	69.4 M	19.8 M	-	-	-	-	-	-	-
Shares	43.3 M	24.1 M	13.2 M	3.42 M	-	-	-	-	-	-	-
Historical Prices	1.7	2.66	5.27	5.8	-	-	-	-	-	-	-
Net Income	-47.1 M	-50.5 M	-43.8 M	-33 M	-29.9 M	-19.1 M	-	-	-	-	-
Revenue	-	-	7 M	5 M	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-52.3 M	-54.2 M	-46.9 M	-38.2 M	-31.3 M	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-52.2 M	-54.1 M	-46.8 M	-38 M	-29.8 M	-18.9 M	-	-	-	-	-
Operating Expenses	52.3 M	50.7 M	51.6 M	37.9 M	-	-	-	-	-	-	-
General and Administrative Expenses	15.2 M	13.2 M	13.8 M	10.2 M	5.6 M	3.33 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Entasis Therapeutics Holdings

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	47.9 M	47.9 M	47.3 M	41.1 M	37.1 M	36.6 M	35.5 M	17.1 M	13.3 M	13.3 M	13.1 M	13.1 M	13.1 M	13.1 M	867 K	12.6 K	12.6 K	12.6 K	1.63 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-15.3 M	-	-12.4 M	-12 M	-10.7 M	-	-11.1 M	-13.4 M	-15.3 M	-	-3.48 M	-13.4 M	-12.9 M	-	-8.47 M	-5.73 M	-10.7 M	-	-8.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	7 M	-	-	-	-8.47 M	5 M	-	-	-8.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-15.9 M	-	-13.6 M	-13.3 M	-12.7 M	-	-12.6 M	-13.5 M	-15.4 M	-	-4.13 M	-14.1 M	-14.2 M	-	-10.2 M	-7.03 M	-11.8 M	-	-8.51 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-15.9 M	-	-13.6 M	-13.3 M	-12.6 M	-	-12.5 M	-13.4 M	-15.4 M	-	-4.02 M	-14 M	-14.2 M	-	-10 M	-6.94 M	-11.7 M	-	-8.37 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	15.9 M	-	13.6 M	13.3 M	12.7 M	-	12.6 M	13.5 M	15.4 M	-	11.1 M	14.1 M	14.2 M	-	10.2 M	12 M	11.8 M	-	8.51 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	4.94 M	-	4.32 M	3.31 M	3.31 M	-	3.21 M	3.24 M	3.78 M	-	3.52 M	3.42 M	3.19 M	-	2.08 M	2.55 M	3.22 M	-	1.35 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency